Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
about
AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in miceTransactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchCell-surface receptors transactivation mediated by g protein-coupled receptorsUnravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approachesRole of redox signaling in neuroinflammation and neurodegenerative diseasesLipid phosphate phosphatases and their roles in mammalian physiology and pathologyEtk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathwayBlockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularizationHIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathwayMesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferationSphingolipid modulation of angiogenic factor expression in neuroblastoma.Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis.Prediction of sphingosine 1-phosphate-stimulated endothelial cell migration rates using biochemical measurementsPerfusable branching microvessel bed for vascularization of engineered tissues.Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives.The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation.Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthmaProtein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.Placental growth factor is a potent vasodilator of rat and human resistance arteries.Alcohol and maternal uterine vascular adaptations during pregnancy-part I: effects of chronic in vitro binge-like alcohol on uterine endothelial nitric oxide system and function.Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degenerationCancer treatment strategies targeting sphingolipid metabolism.Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases.Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors.HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humansThe Genome-Wide Expression Profile of Saussurea lappa Extract on House Dust Mite-Induced Atopic Dermatitis in Nc/Nga Mice.Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunctionSphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds.Hypoxia induced CCL28 promotes angiogenesis in lung adenocarcinoma by targeting CCR3 on endothelial cells
P2860
Q24318212-9BC7015D-4669-4222-A1DB-20D4D6A35B20Q26771727-9B2F1D05-B624-4283-A9A9-39261AE9A563Q26827583-7B3C446E-5735-475B-8E07-5454E9A87519Q27008332-B8795D17-FFF2-4AB2-815C-E0AEA224367BQ27012569-92254C62-6C9C-495B-9325-95CAA0484509Q28088430-EDEA8861-462F-4B9C-8BB9-647E6CF92EB8Q28207963-2EEC8D7B-56A1-41E3-ADBA-D1952DC6886DQ28293429-72BB4499-F75B-42E6-8EB6-C7FC9B084F85Q28538396-225BDFAA-EC6B-484A-99E8-A95E2ADF5D97Q28543375-15EE644B-5C50-437C-93D3-E659C311B92DQ30425699-841A641F-2E88-4F2D-A151-DE88BBCE1537Q30479648-2CF0DA00-527E-4B50-97DC-273A862A18C8Q30495389-842A6E66-84E7-4393-9F20-0B938EC9F6EEQ30530486-A927C320-3950-412E-A8C5-B86320DA4FD2Q33362774-E2931FD0-2275-4F42-BB0D-DDFDB5AFDE46Q33578718-01D0348A-9C2F-4D87-A370-A25D46429C2AQ33770369-868AF608-3032-4062-8DCB-311134904234Q33773550-9BE037E6-8BAD-4CC4-B72F-0956D592EC7CQ33931826-554E65FD-2580-4871-97AE-1371ECFBBA42Q33974608-DE759A0C-9FCE-43D6-821E-A26586AF3487Q34052025-92223F0B-4DB3-467F-9394-1DE64F22AA68Q34562698-425AC9C5-AFB6-4B14-BBC9-9DFFEABB9889Q34678040-34E46AB4-FA20-4DF0-9299-89A832AA7A9CQ34790629-909A199A-F139-4690-B174-4DB311ACB7B8Q35048357-FA4C545B-E7D0-4FF5-A31E-FEAACC2E5446Q35130512-6EB90237-AE79-4336-A90F-C5AC8C6CCAD4Q35192636-F0AC300B-E12E-42D7-B51B-4E7761C22CEAQ35532669-C33FF6B9-03AC-4185-BA07-04AF2E6B2015Q35977376-B7654B03-D76A-49AE-88C5-D577340BBF55Q36056673-F25AD5C7-D73C-467F-B76F-F3AB8CF2177FQ36094099-56A14D0A-E7A2-45D8-9BEE-F289E0E0A8E7Q36100725-65AFD023-A780-48B4-B3CA-C2462FC6B74BQ36107242-8FAB94B1-3181-403E-9318-FE4856248798Q36173954-06384090-586C-4F09-B20B-5E758093EA9BQ36450466-C76898FD-F5B2-4787-AB3F-0E24B8FF780DQ36537740-D229757C-9264-4093-AB42-74BDA1AEECD5Q36544702-00BEEFBB-88CD-4E1E-9F68-8A509E684030Q36727413-3F8AEE47-EBE1-4D57-AB94-2D3FA036A4D5Q36759605-C3B3707F-1749-4E39-9E9E-94A3EAFF8461Q36959390-7C88A1E3-CDAF-4D8D-915B-B8A641DF2B14
P2860
Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Transactivation of vascular en ...... nitric-oxide synthase (eNOS).
@en
type
label
Transactivation of vascular en ...... nitric-oxide synthase (eNOS).
@en
prefLabel
Transactivation of vascular en ...... nitric-oxide synthase (eNOS).
@en
P356
P1476
Transactivation of vascular en ...... nitric-oxide synthase (eNOS).
@en
P2093
Tatsuo Tanimoto
Zheng-Gen Jin
P304
42997-43001
P356
10.1074/JBC.M204764200
P407
P577
2002-09-10T00:00:00Z